The European Association for Cancer Research
Advancing cancer research - from basic research to prevention, treatment and care
About EACR
The European Association for Cancer Research (EACR) was established in 1968 with the aim of advancing cancer research; from basic research to prevention, treatment and care. The Association is growing rapidly with a membership of over 8,000 laboratory, translational and clinical cancer researchers.
Meetings
Save the Dates:
16th ECCO-36th ESMO Multidisciplinary Congress, Stockholm 23-27 September 2011
EACR’s Biennial Meeting: EACR-22, Barcelona, 7-10 July 2012
Fellowships and Bursaries
EACR fellowships mainly give opportunities for researchers to work in exciting new contexts across Europe. They support the development of research and participation in workshops and courses. Meeting bursaries are also awarded to assist student members, and members with less than ten years post-doctoral experience, to attend EACR’s main scientific meetings.
Eurocancercoms
The Eurocancercoms project aims to establish a single, efficient network for cancer communication in Europe. Click here to find out how EACR members are invited to make an active contribution to this important project. Funded by the European Commission under FP7.
Newsletter and e-news bulletins
Our Annual Newsletter is published in the spring and has reports on meetings, awards and fellowships, news from national society members, and other informative features. EACR members also receive weekly e-news bulletins containing valuable information about meetings and activities.
EACR Executive Committee and Council
Julio Celis, President of EACR (Pictured)
The Executive Committee conducts the affairs of the Association and is advised by the EACR Council.
Executive Committee and Council membership can be found here >
Sustaining Members
Through Sustaining Membership, the European Association for Cancer Research forms valuable partnerships with selected organisations. Sustaining Members support the vital work of EACR in its fight against cancer and provide the means for the Association to develop.
ECCO – European CanCer Organisation
EACR is a founding member of the European Cancer Organisation (ECCO).
EACR maintains an influential position in European cancer policy initiatives, educational activities and scientific debate as a founder member of the European Cancer Organisation. Through ECCO, EACR enjoys strong links and partnerships with other European cancer societies.
Journals Plus
EACR’s official journal is The European Journal of Cancer.
Members have free access to the e-book edition of ‘ European Oncology’. Special Member discounts and offers from publishers Springer and Wiley-Blackwell.
Members Only
Members Area Log in. Keep your contact information up to date to make sure you never miss a weekly e-news bulletin or Newsletter mailing. Join or start a discussion in the Researchers Forum.
Join Today
Membership of EACR confers many benefits. Read more here and apply on-line.
Post-graduate students may apply for free membership.
Contact us
The EACR offices are based in the U.K. at the University of Nottingham. Click here to submit a query through our online contact form or for full contact details >
Members' Log in
Latest News
EACR-21 participants praise quality of the Scientific Programme in Feedback Survey
Results of EACR members Survey for Eurocancercoms published and further comments invited
New Updated Guidelines for the Welfare and Use of Animals in Cancer Research
2010 EACR Year Book now available online:
2010 EACR Award winners announced
Members' Items
e-news bulletin, SPAM filters and Junk Mail
2009 Summer Symposia Programme Book and Abstracts are now available to members online
View newsletters, publications and surveys >
European Journal of Cancer - Online Subscription offer
Keep contact details up to date to receive regular EACR news by e-mail and air-mail
2010 Membership Fees: Information about Invoicing and Payment Methods
Jobs and Study Opportunities
Click a title for full information
Latest Opportunitities
Post-doctoral Position, Vall d’Hebron Institute of Oncology, Barcelona
World Cancer Research Fund (WCRF) International: Application Announcement for 2010/11 Grant Cycle
Director, Drug Discovery, Sage Bionetworks, Seattle, WA
